NEUROMARK Registry Study

Running, not enrolling · Not applicable

Conditions studied: Chronic Rhinitis

In brief

The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.

Key facts

Study ID

NCT05937308

Run by

Neurent Medical

People needed

150

Starts

2023-06-12

Expected to finish

2027-09-01

Last updated by the study team

2026-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject MUST:
• Be ≥18 years of age.
• Be scheduled to receive treatment with the commercially available NEUROMARK System consistent with the device's indications for use.
• Have moderate to severe symptoms of running nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptom rating of 1, 2, or 3), and a minimum total score of 5 (out of 12) at screening.
• Be willing and able to provide consent and comply with all study elements, as indicated by written informed consent.

You may not qualify if…

• Subjects Must Not:
• Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.

Where it is running

• Alabama Nasal & Sinus Center — Birmingham, Alabama, United States
• Sensa Health — Los Angeles, California, United States
• Sacramento ENT — Roseville, California, United States
• Florida ENT & Allergy — Brandon, Florida, United States
• ENT & Allergy Texas — McKinney, Texas, United States
• Ogden Clinic — Ogden, Utah, United States
• Metropolitan ENT — Alexandria, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.